Immunomodulatory therapies delay disease progression in multiple sclerosis

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

(2010) G. C. Ebers et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

(2009) M. Trojano et al.   ANNALS OF NEUROLOGY

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

(2009) G Comi et al.   LANCET

Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

(2009) DS Goodin et al.   Multiple Sclerosis Journal

The search for a balance between short and long-term treatment outcomes in multiple sclerosis

(2008) Ulf Baumhackl   JOURNAL OF NEUROLOGY

Natural history of secondary-progressive multiple sclerosis

(2008) Helen Tremlett et al.   Multiple Sclerosis Journal

Disability as an outcome in MS clinical trials

(2008) G. C. Ebers et al.   NEUROLOGY